Data / Form D filings / SeqOnce BioSciences, Inc.
SeqOnce BioSciences, Inc.: Form D filings
SeqOnce BioSciences, Inc., a biotechnology company in Pasadena, CA, filed 2 Form D notices with the SEC between 2018 and 2024. The latest, on November 5, 2024, reports $881,831 sold of a $881,831 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2265 E. FOOTHILL BOULEVARD, Pasadena, CA, 91107
- Phone
- (626) 765-3894
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1655808
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | New notice | $881,831 | $881,831 | 4 | Oct 14, 2024 | sec.gov | |
| Apr 27, 2018 | New notice | $1,220,911 | $1,010,909 | $210,002 | 12 | Apr 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Angermayer | Executive Officer, Director | |
| Joseph Dunham | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 4, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SeqOnce BioSciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.